ProKidney Corp. (PROK) Tops Q2 EPS by 18c

ProKidney Corp. (NASDAQ: PROK) reported Q2 EPS of ($0.14), $0.18 better than the analyst estimate of ($0.32).

For earnings history and earnings-related data on ProKidney Corp. (PROK) click here.

You May Also Be Interested In

• Are we witnessing a fundamental or speculative rally in the S&P 500?
• Morgan Stanley backs Yum Brands, cuts Chipotle rating as growth outlook diverges
• Veeva Systems (VEEV) Tops Q1 EPS by 10c, Offers Guidance